# A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

> **NCT05684289** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 61 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986278
- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05684289
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-03
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-02
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05684289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05684289, "A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05684289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*